Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
PUT
Enbridge
ENB
$109B
| $3.48M | ﹤0.01% |
78,800
+67,400
| +591% | +$2.83M |
|
2677
CALL
Eversource Energy
ES
$26.7B
| $3.48M | ﹤0.01% |
64,300
-35,100
| -35% | -$1.98M |
|
2678
First Trust Switzerland AlphaDEX Fund
FSZ
$37.2M
| $3.48M | ﹤0.01% |
84,739
+61,004
| +257% | +$2.43M |
|
|
AMID
2679
CALL
DELISTED
American Midstream Partners, LP
AMID
| $3.48M | ﹤0.01% |
235,900
+4,300
| +2% | +$54.9K |
|
2680
CALL
Suburban Propane Partners
SPH
$1.17B
| $3.48M | ﹤0.01% |
104,600
-115,500
| -52% | -$3.9M |
|
2681
PUT
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $3.48M | ﹤0.01% |
112,500
-70,000
| -38% | -$2.16M |
|
2682
PUT
Encore Capital Group
ECPG
$2.16B
| $3.48M | ﹤0.01% |
154,800
+48,700
| +46% | +$1.1M |
|
2683
Cirrus Logic
CRUS
$5.56B
| $3.48M | ﹤0.01% |
65,422
| – | – |
|
2684
Quad
QUAD
$518M
| $3.48M | ﹤0.01% |
130,060
+34,833
| +37% | +$924K |
|
2685
PUT
IMAX
IMAX
$2.85B
| $3.47M | ﹤0.01% |
119,900
+87,700
| +272% | +$2.67M |
|
2686
Prudential Financial
PRU
$41.5B
| $3.47M | ﹤0.01% |
42,528
-200,020
| -82% | -$15.3M |
|
2687
FirstCash
FCFS
$9.72B
| $3.47M | ﹤0.01% |
+73,732
| New | +$3.71M |
|
|
NBL
2688
DELISTED
Noble Energy, Inc.
NBL
| $3.47M | ﹤0.01% |
97,100
| – | – |
|
2689
PUT
ProShares Ultra Energy
DIG
$79.8M
| $3.46M | ﹤0.01% |
72,080
-21,600
| -23% | -$991K |
|
|
VAR
2690
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.45M | ﹤0.01% |
39,571
+1,482
| +4% | +$121K |
|
2691
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$99.8B
| $3.45M | ﹤0.01% |
41,300
-64,600
| -61% | -$5.38M |
|
|
CYBR
2692
DELISTED
CyberArk
CYBR
| $3.45M | ﹤0.01% |
69,555
-58,186
| -46% | -$3.1M |
|
|
AMSG
2693
PUT
DELISTED
Amsurg Corp
AMSG
| $3.45M | ﹤0.01% |
51,400
+21,100
| +70% | +$1.47M |
|
2694
PUT
Trane Technologies
TT
$100B
| $3.44M | ﹤0.01% |
50,700
+17,500
| +53% | +$1.17M |
|
|
STRP
2695
PUT
DELISTED
Straight Path Communications Inc.
STRP
| $3.44M | ﹤0.01% |
134,500
-62,200
| -32% | -$1.49M |
|
|
AWH
2696
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $3.44M | ﹤0.01% |
85,188
+43,131
| +103% | +$1.7M |
|
2697
Gentex
GNTX
$4.86B
| $3.44M | ﹤0.01% |
195,949
-91,137
| -32% | -$1.57M |
|
2698
CALL
Globalstar
GSAT
$10.6B
| $3.44M | ﹤0.01% |
189,613
-106,900
| -36% | -$2.01M |
|
|
FLTX
2699
PUT
DELISTED
Fleetmatics Group PLC
FLTX
| $3.44M | ﹤0.01% |
57,300
+43,200
| +306% | +$2.36M |
|
2700
CALL
Spectrum Brands
SPB
$2.04B
| $3.43M | ﹤0.01% |
24,900
-3,200
| -11% | -$407K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.